
|Articles|April 1, 2017
- Pharmaceutical Executive-04-01-2017
- Volume 37
- Issue 4
Pharmaceutical Executive, April 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive April 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
HBA's Woman of the Year 2017about 9 years ago
Sales Force Effectiveness, Millennial Styleabout 9 years ago
The Lengthening Arm of Pharmacovigilanceabout 9 years ago
When Rare Becomes Commonabout 9 years ago
Advancing Rare Disease R&D: A Mission Updateabout 9 years ago
A Faster, More Flexible, and Frugal FDA?about 9 years ago
Country Report: GreeceAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
2
Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma
3
The New Healthy Aging Imperative and What It Means for Pharma
4
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
5




